ALAB vs. ANAB
ALAB (Astera Labs, Inc.) and ANAB (AnaptysBio, Inc.) are both stocks. ALAB operates in Semiconductors (Technology), while ANAB operates in Biotechnology (Healthcare). Over the past year, ALAB returned 127.62% vs 226.03% for ANAB. Their 0.12 correlation means their historical movements had little consistent relationship.
Performance
ALAB vs. ANAB - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ALAB achieves a 87.08% return, which is significantly higher than ANAB's 65.10% return.
ALAB
- 1D
- 3.85%
- 1M
- -27.77%
- 6M
- 106.63%
- YTD
- 87.08%
- 1Y
- 127.62%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- 112.28%
ANAB
- 1D
- -3.05%
- 1M
- -18.45%
- 6M
- 68.83%
- YTD
- 65.10%
- 1Y
- 226.03%
- 3Y*
- 57.31%
- 5Y*
- 28.35%
- 10Y*
- —
- ALL TIME*
- 18.45%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $1.26B | $1.54B | $1.91B | |
ANAB AnaptysBio, Inc. | $39.97M | $46.98M | $40.05M |
ALAB vs. ANAB - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
ALAB Astera Labs, Inc. | 87.08% | 25.60% | 152.00% |
ANAB AnaptysBio, Inc. | 65.10% | 266.16% | -43.10% |
Correlation
The correlation between ALAB and ANAB is 0.17, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.17 |
Correlation (All Time) Calculated using the full available price history since Mar 20, 2024 | 0.12 |
Fundamentals
ALAB:
$53.35B
ANAB:
$2.30B
ALAB:
$1.48
ANAB:
-$0.90
ALAB:
56.25
ANAB:
6.82
ALAB:
37.74
ANAB:
120.10
ALAB:
$1.00B
ANAB:
$232.39M
ALAB:
$760.99M
ANAB:
$245.59M
ALAB:
$253.12M
ANAB:
$52.72M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ALAB vs. ANAB — Risk / Return Rank
ALAB
ANAB
ALAB vs. ANAB - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Astera Labs, Inc. (ALAB) and AnaptysBio, Inc. (ANAB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ALAB | ANAB | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.82 | ||
| Sortino ratioReturn per unit of downside risk | -1.30 | ||
| Omega ratioGain probability vs. loss probability | 1.26 | 1.45 | -0.19 |
| Calmar ratioReturn relative to maximum drawdown | 2.13 | 8.14 | -6.01 |
| Martin ratioReturn relative to average drawdown | 4.03 | 19.84 | -15.81 |
Loading charts...
Drawdowns
ALAB vs. ANAB - Drawdown Comparison
The maximum ALAB drawdown since its inception was -63.69%, smaller than the maximum ANAB drawdown of -92.08%. Use the drawdown chart below to compare losses from any high point for ALAB and ANAB.
Loading charts...
Drawdown Indicators
| ALAB | ANAB | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -63.69% | -92.08% | +28.39% |
Max Drawdown (1Y)Largest decline over 1 year | -60.19% | -27.96% | -32.23% |
Max Drawdown (3Y)Largest decline over 3 years | — | -69.32% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -69.32% | — |
Current DrawdownCurrent decline from peak | -35.57% | -37.74% | +2.17% |
Average DrawdownAverage peak-to-trough decline | -29.00% | -64.17% | +35.17% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 31.79% | 11.45% | +20.34% |
Volatility
ALAB vs. ANAB - Volatility Comparison
Astera Labs, Inc. (ALAB) has a higher volatility of 34.17% compared to AnaptysBio, Inc. (ANAB) at 27.46%. This indicates that ALAB's price experiences larger fluctuations and is considered to be riskier than ANAB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ALAB | ANAB | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 34.17% | 27.46% | +6.71% |
Volatility (6M)Calculated over the trailing 6-month period | 77.73% | 51.26% | +26.47% |
Volatility (1Y)Calculated over the trailing 1-year period | 100.79% | 73.55% | +27.24% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 95.32% | 66.36% | +28.96% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 95.32% | 75.51% | +19.81% |
Dividends
ALAB vs. ANAB - Dividend Comparison
Neither ALAB nor ANAB has paid dividends to shareholders.
Financials
ALAB vs. ANAB - Financials Comparison
This section allows you to compare key financial metrics between Astera Labs, Inc. and AnaptysBio, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ALAB and ANAB have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ALAB has higher volatility (34.17%) compared to ANAB (27.46%). In terms of maximum drawdown, ALAB dropped -63.69% vs ANAB's -92.08%.
ANAB currently has the higher Sharpe Ratio (3.10 vs 1.28), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ALAB and ANAB
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer